Tempest Therapeutics stockholders approve reverse stock split proposal at ratios up to 1-for-15

Tempest Therapeutics, Inc.

Stockholders approved reverse stock split proposal at special meeting on December 3, 2024.
Ratio range: 1-for-2 to 1-for-15, inclusive, with board to set final ratio in its discretion.
Vote results: 12,723,707 for, 9,810,591 against, 415,687 abstentions.
On December 5, 2024, entered Amendment No. 2 to Rights Agreement for technical board administration changes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.